Resource Library

Let’s recognize what’s really going on when we cope with comfort food.

Obesity isn’t a willpower problem, and it never was.

Obesity is a growing health concern and many still face significant barriers to accessing obesity care. Employers who invest in providing obesity care can foster a healthier, more engaged workforce, while reducing healthcare costs.

Join Dr. Fatima Cody Stanford, Dr. Richard Frank, and Veeneta Lakhani as they break down what toda’ys evolving treatment landscape means for benefit leaders, payers, and consultants.

What are the key considerations to ensure members are supported during a formulary change, and how can we ensure that people continue progressing toward better health, even if their coverage changes?

Following our recent webinar with Amwell, Dr. Cynthia Horner, chief medical officer for Amwell, explored the issues plaguing the healthcare industry when it comes to cardiometabolic health and whole-person care.

With data from over 18,000 members, this infographic highlights the measurable success of Vida’s personalized, cost-effective approach to obesity care. Learn how our model supports sustainable weight loss, promotes smart medication use, and delivers an immediate return on investment for employers and health plans.

Obesity rates in the US are soaring, especially among low-income and minority communities. Yet these same groups face the steepest barriers to accessing effective treatments like GLP-1s.

Almost half of people with excess weight turn to GLP-1s as a first-line treatment, leading to less sustainable outcomes and rising healthcare costs. By partnering with Vida, we are improving access to obesity specialty care and helping organizations manage costs
and deliver better results.

Download our newest case study to learn how you can lower costs and provide better wraparound solutions for your people with Vida.

Download our newest case study with SISC to learn how your people can also live a happier, healthier future with Vida.

Member Story

Among the 47 million Americans living with cardiometabolic disorders, people of color are disproportionately affected, particularly Hispanic Americans.